Improving Services and Outcomes for Children With Autism Spectrum Disorder (ASD)

NCT ID: NCT01800539

Last Updated: 2022-07-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-02-28

Study Completion Date

2022-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Based on the need to characterize and improve early intervention services for minority and under-resourced children with ASD, this study translates a manualized and proven training model to examine its impact on the use of evidence-based practices (EBP) by early intervention providers, and to examine its relationship to child and family outcomes. By highlighting the impact of EBP-focused training on participating providers, children, and families, findings of the proposed study have the potential to effect significant change in the organization and delivery of early intervention services for minority and under-resourced children with ASD.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Autism Spectrum Disorders

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Provider Education Model (PEM)

condition wherein providers will receive specially structured training during their typical home visits based by Kennedy Krieger Institute (KKI) staff

Group Type EXPERIMENTAL

Provider Education Model (PEM)

Intervention Type BEHAVIORAL

Providers will be trained to use evidence-based practices for early intervention service delivery in the Autism Spectrum Disorder population.

Treatment-as-Usual (TAU)

condition wherein providers continue with their existing practices

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Provider Education Model (PEM)

Providers will be trained to use evidence-based practices for early intervention service delivery in the Autism Spectrum Disorder population.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Providers must be employed by an Infants and Toddlers Program; and
* Serve at least one eligible child with ASD


* Children must be between 12 months, 0 days and 35 months, 30 days of age at entry into the study;
* Children must meet criteria on the Autism Diagnostic Observation Schedule (ADOS) for ASD or autism; and
* Caregiver and child must be available for all assessments

Exclusion Criteria

* Children will be excluded if they are in foster care or wards of the state
* Caregiver must be fluent in speaking and understanding the English language
Minimum Eligible Age

12 Months

Maximum Eligible Age

42 Months

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Health Resources and Services Administration (HRSA)

FED

Sponsor Role collaborator

Hugo W. Moser Research Institute at Kennedy Krieger, Inc.

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Rebecca Landa

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Rebecca Landa, PhD, CCC-SLP

Role: PRINCIPAL_INVESTIGATOR

Hugo W. Moser Research Institute at Kennedy Krieger, Inc.

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Kennedy Krieger Institute

Baltimore, Maryland, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NA_00023642

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

DOD Regulating Together Intervention
NCT05803369 RECRUITING NA
A Novel Framework for Impaired Imitation in ASD
NCT03423160 ACTIVE_NOT_RECRUITING